When you're developing a new car you have to do a lot of general R&D and a lot of car-specific R&D. What gets charged against the car and what are considered general? Who gets to decide? Why would they decide in a particular way?
It's not super obvious to me where you'd bill things even if they're ostensibly just for the Model S because in another year or two they might release a Model S2 with not a lot of R&D because they just stole parts from the Model S, Model X and Model 3.
Not saying it will happen, but it could. Then the R&D costs would be too low on that car and they'd have to go back and adjust their gross margin back as far as they've been selling the other cars and then the whole thing is a nightmare since I'm pretty sure the SEC won't let you do that.
Analyzing an investment in Tesla according to the rules you use for GM or Daimler is going to lose you a lot of money. Or realistically already has -- most people whining are whining because they didn't get in on the Tesla boom and are looking for reasons to prove it's a bubble.
Please don't be personally rude on HN. This comment would be fine with just the first sentence.
Another way that Tesla is different is that they don't announce monthly sales numbers. That means that a fair number of analysts ignore them; here's an example [1].
http://www.nytimes.com/2015/07/02/business/us-monthly-auto-s...